Glucosamine Use May Accelerate Alzheimer’s Progression, UF Study Finds
TL;DR
UF Health analyzed records from 2012–2024 plus brain tissue and mouse studies and found glucosamine use associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia and a 25% higher mortality in Alzheimer's disease patients. The research points to a hyperactive protein sugar-tagging (glycosylation) pathway as a potential mechanism, suggesting metabolic dysfunction may drive progression, though causality isn’t proven and clinical trials are needed.
Topics:healthhealth-and-medicine#alzheimers-disease#dementia#glucosamine#health-and-medicine#metabolism#neurodegeneration
- Popular joint supplement glucosamine linked to faster Alzheimer’s progression ScienceDaily
- Study links joint pain supplement to accelerating dementia EurekAlert!
- Glucosamine supplements may speed memory loss from Alzheimer’s, new research shows The Conversation
- Alzheimer's May Be Worse for People Taking Popular Supplement MedPage Today
- Glucosamine May Contribute to Alzheimer’s Disease Pain News Network
Want the full story? Read the original reporting
Read on ScienceDaily